In particular, LTβR expression has been noted in ovarian cancer cells and their CAFs [50] while activation of the LTβR pathway has been previously reported in breast, colorectal, lung, larynx/pharynx, gastric cancers [51] and melanomas [52]. This evidence concerns the gene LTBR and ovarian carcinoma.